Products for Research Use Only
RegisterLogin

Selicrelumab

CAT: 0804-HY-P99046-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99046-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Selicrelumab is an agonist CD40 antibody, induces changes in the tumor microenvironment. Selicrelumab can be used for the research of pancreatic cance and neoadjuvant study[1].
CAS Number
1622140-49-1
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/selicrelumab.html
Purity
97.64
Solubility
H2O
Smiles
[Selicrelumab]
Molecular Weight
(146.2 kDa)
References & Citations
[1]Katelyn T Byrne, Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer. Clin Cancer Res. 2021 Aug 15;27 (16) :4574-4586.|[2]Delgado R, et al., Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia. Cancers (Basel) . 2021 Jun 21;13 (12) :3084.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
T78250-01Selicrelumab
GTR18399512-01Selicrelumab Antibody
592185Selicrelumab (CD40, TNFRSF5)
WA3515Research Grade Selicrelumab
KBI1619KRIBIOLISA™ Selicrelumab ELISA
MBS1586391-01Selicrelumab ELISA Kit
E55B0336Selicrelumab (Reference antibody)
ICH5032-1gSelicrelumab Biosimilar - Research Grade
C00528-1mgSelicrelumab (Anti-TNFRSF5 / CD40)
ABS-253-100ugSelicrelumab Biosimilar, Research Grade

Popular Products